Details for 2021716724

Up to date per 02.04.2026

Actions

Title / Product Name

DAPAGLIFLOZIN ZUR VERWENDUNG IN DER BEHANDLUNG VON CHRONISCHEN NIERENERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021716724

EP Publication Number

4188389

E-Number

1837722

Language

PCT Number

EP21058727

Publication Date

07.06.2023 A

17.09.2025 B1

Registration Date

17.09.2025

AT Publication Date

15.10.2025

Application Date

01.04.2021

Registration Number

Priorities

27.07.2020

202063057139 P

27.08.2020

202063070869 P

24.09.2020

202063082524 P

20.10.2020

202063093961 P

01.12.2020

202063119711 P

23.02.2021

202163152445 P

16.03.2021

202163161629 P

IPC

A61K 31/70 20060101AFI20220204BHEP

Maximum Duration of Protection

01.04.2041

Owner

AstraZeneca AB 151 85 SödertäljeSE

Representative

No representatives present

Inventor

LANGKILDE, Anna Maria 151 85 SödertäljeSE

Information about Fees